Dynamic treatment regimes (DTRs) to study treatment sequencing in oncology: a scoping review protocol

• Published in: BMJ open Vol. 13; no. 5; p. e067192
• Main Authors: Esteves, Susana, Alves, João Miguel, Rodrigues, Pedro Pereira, Gomes da Silva, Maria
• Format: Journal Article
• Language: English
• Published: England British Medical Journal Publishing Group 30.05.2023; BMJ Publishing Group LTD; BMJ Publishing Group
• Series: Protocol
• Subjects: Cancer; Chronic illnesses; Clinical medicine; Clinical trials; Disease; Humans; Medical Oncology; Methods; ONCOLOGY; Patients; Research Design; Research Methods; Review Literature as Topic; STATISTICS & RESEARCH METHODS; Systematic Review; THERAPEUTICS; THERAPEUTICS; ONCOLOGY; STATISTICS & RESEARCH METHODS; Systematic Review
• ISSN: 2044-6055; 2044-6055
• DOI: 10.1136/bmjopen-2022-067192

IntroductionThe rapid evolution of the therapeutic landscape in oncology poses challenges to optimal treatment sequencing. Evidence for clinical decision-making is often limited to studies focused on treatment evaluation at a single decision point, with limited capability of identifying delayed effects of prior treatment decisions on the efficacy and feasibility of future treatments. There is a growing interest in dynamic treatment regimes (DTRs) evaluation as it provides guidance on treatment individualisation based on evolving treatment and patient characteristics. In this scoping review we aim to systematically map how and to what extent DTRs have been evaluated in clinical studies to generate evidence for clinical decision-making in oncology.Methods and analysisWe will do a systematic literature search in MEDLINE (PubMed), Web of Science, Scopus and WHO international clinical trials registry platform to identify clinical studies (including protocols of ongoing studies), with either experimental or observational design, that aim to answer a clinical question and explore treatment sequencing issues in oncology using the concept of DTR. Data extraction will comprise information concerning cancer disease, clinical setting, treatments, tailoring variables, decision rules, decision points and outcomes, type of data, study design and statistical methods used for DTR evaluation. The review will be conducted according to Joanna Briggs Institute Reviewer’s manual for scoping reviews. No patients will be involved.Ethics and disseminationEthics committee approval is not required as this scoping review will undertake secondary analysis of published literature. Results will be disseminated through a peer-reviewed scientific journal and presented in relevant conferences. This scoping review will provide a better understanding of the methods used to generate evidence on treatment sequencing in oncology and will contribute to the identification of knowledge and methodological gaps that should be addressed.